Carregant...

Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome

BACKGROUND: Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by arterial or venous thrombosis (or both) and/or pregnancy morbidity in association with the presence of antiphospholipid antibodies. The prevalence is estimated at 40 to 50 cases per 100,000 people. The most...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cochrane Database Syst Rev
Autors principals: Bala, Malgorzata M, Celinska‐Lowenhoff, Magdalena, Szot, Wojciech, Padjas, Agnieszka, Kaczmarczyk, Mateusz, Swierz, Mateusz J, Undas, Anetta
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2017
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6485894/
https://ncbi.nlm.nih.gov/pubmed/28968483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012169.pub2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!